According to the research report, the global cell-based assays market size is expected to touch USD 42.32 Billion by 2032, from USD 17.83 Billion in 2022, growing with a significant CAGR of 9.03% from 2023 to 2032. 

The report offers intricate dynamics about different aspects of the global cell-based assays market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global cell-based assays during the Forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/2982

This study covers a detailed segmentation of the global cell-based assays market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global cell-based assays market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

• Danaher Corporation
• Lonza Group AG
• Promega Corporation
• F. Hoffmann-La Roche AG
• Charles River Laboratories International, Inc.
• Menarini Silicon Biosystems, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Macrogen Inc
• DiscoverX Corporation
• Corning Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Perkinelmer, Inc.
• Biognosys
• Cell Signaling Technology, Inc.
• Lebermuth, Inc.
• Eurofins DiscoverX Products
• AAT Bioquest, Inc.
• GE Healthcare
• Beckman Coulter,Inc.

Market Segmentation

By Type

• Cell Viability Assay
• Cytotoxicity Assay
• Cell Death Assay
• Cell Proliferation Assay
• Others

By Products & Services

• Reagents
• Assay Kits
  • Cell Growth Assays
  • Reporter Gene Assays
  • Cell Death Assays
  • Second Messenger Assays
• Microplates
• Probes & Labels
• Instruments & Software
• Cell Lines
  • Primary Cell Lines
  • Stem Cell Lines
  • Immortalized Cell Lines

By Application

• Basic Research
• Drug Discovery
• Other Applications

By Technology

• Automated Handling
• Flow Cytometry
• Label-free Detection
• High-throughput Screening
• Others

By End-use 

• Pharmaceutical and Biotechnology Companies
• Academic & Government Institutes
• Contract Research Organizations

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Research Methodology

The research methodology adopted by analysts for compiling the global cell-based assays report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global cell-based assays market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cell-based Assays Market 

5.1. COVID-19 Landscape: Cell-based Assays Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cell-based Assays Market, By Type

8.1. Cell-based Assays Market, by Type, 2023-2032

8.1.1. Cell Viability Assay

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Cytotoxicity Assay

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Cell Death Assay

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Cell Proliferation Assay

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Cell-based Assays Market, By Products & Services

9.1. Cell-based Assays Market, by Products & Services, 2023-2032

9.1.1. Reagents

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Assay Kits

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Microplates

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Probes & Labels

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Instruments & Software

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Cell Lines

9.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Cell-based Assays Market, By Application 

10.1. Cell-based Assays Market, by Application, 2023-2032

10.1.1. Basic Research

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Drug Discovery

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Other Applications

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Cell-based Assays Market, By Technology

11.1. Cell-based Assays Market, by Technology, 2023-2032

11.1.1. Automated Handling

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Flow Cytometry

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Label-free Detection

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. High-throughput Screening

11.1.4.1. Market Revenue and Forecast (2020-2032)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Cell-based Assays Market, By End-use

12.1. Cell-based Assays Market, by End-use, 2023-2032

12.1.1. Pharmaceutical and Biotechnology Companies

12.1.1.1. Market Revenue and Forecast (2020-2032)

12.1.2. Academic & Government Institutes

12.1.2.1. Market Revenue and Forecast (2020-2032)

12.1.3. Contract Research Organizations

12.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 13. Global Cell-based Assays Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2020-2032)

13.1.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.1.3. Market Revenue and Forecast, by Application (2020-2032)

13.1.4. Market Revenue and Forecast, by Technology (2020-2032)

13.1.5. Market Revenue and Forecast, by End-use (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2020-2032)

13.1.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.1.6.3. Market Revenue and Forecast, by Application (2020-2032)

13.1.6.4. Market Revenue and Forecast, by Technology (2020-2032)

13.1.6.5. Market Revenue and Forecast, by End-use (2020-2032) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type (2020-2032)

13.1.7.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.1.7.3. Market Revenue and Forecast, by Application (2020-2032)

13.1.7.4. Market Revenue and Forecast, by Technology (2020-2032)

13.1.7.5. Market Revenue and Forecast, by End-use (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2020-2032)

13.2.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.2.3. Market Revenue and Forecast, by Application (2020-2032)

13.2.4. Market Revenue and Forecast, by Technology (2020-2032) 

13.2.5. Market Revenue and Forecast, by End-use (2020-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2020-2032)

13.2.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.2.6.3. Market Revenue and Forecast, by Application (2020-2032)

13.2.7. Market Revenue and Forecast, by Technology (2020-2032) 

13.2.8. Market Revenue and Forecast, by End-use (2020-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2020-2032)

13.2.9.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.2.9.3. Market Revenue and Forecast, by Application (2020-2032)

13.2.10. Market Revenue and Forecast, by Technology (2020-2032)

13.2.11. Market Revenue and Forecast, by End-use (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2020-2032)

13.2.12.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.2.12.3. Market Revenue and Forecast, by Application (2020-2032)

13.2.12.4. Market Revenue and Forecast, by Technology (2020-2032)

13.2.13. Market Revenue and Forecast, by End-use (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2020-2032)

13.2.14.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.2.14.3. Market Revenue and Forecast, by Application (2020-2032)

13.2.14.4. Market Revenue and Forecast, by Technology (2020-2032)

13.2.15. Market Revenue and Forecast, by End-use (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2020-2032)

13.3.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.3.3. Market Revenue and Forecast, by Application (2020-2032)

13.3.4. Market Revenue and Forecast, by Technology (2020-2032)

13.3.5. Market Revenue and Forecast, by End-use (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2020-2032)

13.3.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.3.6.3. Market Revenue and Forecast, by Application (2020-2032)

13.3.6.4. Market Revenue and Forecast, by Technology (2020-2032)

13.3.7. Market Revenue and Forecast, by End-use (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2020-2032)

13.3.8.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.3.8.3. Market Revenue and Forecast, by Application (2020-2032)

13.3.8.4. Market Revenue and Forecast, by Technology (2020-2032)

13.3.9. Market Revenue and Forecast, by End-use (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2020-2032)

13.3.10.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.3.10.3. Market Revenue and Forecast, by Application (2020-2032)

13.3.10.4. Market Revenue and Forecast, by Technology (2020-2032)

13.3.10.5. Market Revenue and Forecast, by End-use (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2020-2032)

13.3.11.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.3.11.3. Market Revenue and Forecast, by Application (2020-2032)

13.3.11.4. Market Revenue and Forecast, by Technology (2020-2032)

13.3.11.5. Market Revenue and Forecast, by End-use (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2020-2032)

13.4.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.4.3. Market Revenue and Forecast, by Application (2020-2032)

13.4.4. Market Revenue and Forecast, by Technology (2020-2032)

13.4.5. Market Revenue and Forecast, by End-use (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2020-2032)

13.4.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.4.6.3. Market Revenue and Forecast, by Application (2020-2032)

13.4.6.4. Market Revenue and Forecast, by Technology (2020-2032)

13.4.7. Market Revenue and Forecast, by End-use (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2020-2032)

13.4.8.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.4.8.3. Market Revenue and Forecast, by Application (2020-2032)

13.4.8.4. Market Revenue and Forecast, by Technology (2020-2032)

13.4.9. Market Revenue and Forecast, by End-use (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2020-2032)

13.4.10.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.4.10.3. Market Revenue and Forecast, by Application (2020-2032)

13.4.10.4. Market Revenue and Forecast, by Technology (2020-2032)

13.4.10.5. Market Revenue and Forecast, by End-use (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2020-2032)

13.4.11.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.4.11.3. Market Revenue and Forecast, by Application (2020-2032)

13.4.11.4. Market Revenue and Forecast, by Technology (2020-2032)

13.4.11.5. Market Revenue and Forecast, by End-use (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2020-2032)

13.5.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.5.3. Market Revenue and Forecast, by Application (2020-2032)

13.5.4. Market Revenue and Forecast, by Technology (2020-2032)

13.5.5. Market Revenue and Forecast, by End-use (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2020-2032)

13.5.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.5.6.3. Market Revenue and Forecast, by Application (2020-2032)

13.5.6.4. Market Revenue and Forecast, by Technology (2020-2032)

13.5.7. Market Revenue and Forecast, by End-use (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2020-2032)

13.5.8.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.5.8.3. Market Revenue and Forecast, by Application (2020-2032)

13.5.8.4. Market Revenue and Forecast, by Technology (2020-2032)

13.5.8.5. Market Revenue and Forecast, by End-use (2020-2032)

Chapter 14. Company Profiles

14.1. Danaher Corporation

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Lonza Group AG

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Promega Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. F. Hoffmann-La Roche AG

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Charles River Laboratories International, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Menarini Silicon Biosystems, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Becton, Dickinson and Company

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Bio-Rad Laboratories, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Macrogen Inc

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. DiscoverX Corporation

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: [email protected]

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com